Showing 541 - 560 results of 101,427 for search '(( 5 ((nn decrease) OR (mean decrease)) ) OR ( 5 ((mg decrease) OR (a decrease)) ))', query time: 1.56s Refine Results
  1. 541
  2. 542
  3. 543
  4. 544
  5. 545
  6. 546

    The NK1-receptor antagonist ezlopitant significantly decreases voluntary intake of non-caloric saccharin solution. by Pia Steensland (362091)

    Published 2013
    “…<p>Ezlopitant (5 and 10 mg/kg) significantly decreased consumption of the non-caloric 0.2% saccharin solution compared to vehicle. …”
  7. 547

    The NK1-receptor antagonist ezlopitant significantly and selectively decreases voluntary intake of both sucrose and ethanol. by Pia Steensland (362091)

    Published 2013
    “…<p>Ezlopitant decreased consumption of 5% sucrose (<b>A</b>), whereas only the highest dose of ezlopitant (10 mg/kg) decreased consumption of 20% ethanol (<b>B</b>). …”
  8. 548
  9. 549
  10. 550
  11. 551
  12. 552
  13. 553
  14. 554
  15. 555
  16. 556
  17. 557

    Chlorogenic acid (CGA) metabolites-containing serum from CGA-treated normal mice decreases lipid accumulation and stimulates cholesterol efflux from RAW264.7 cells. by Chongming Wu (169161)

    Published 2014
    “…<p>Normal C57BL/6J mice were orally gavaged with 400 mg/kg of CGA or equal volume of distilled water for 3 days and blood was collected at 45 min after the final treatment. 1% (v/v) of serum from CGA-treated normal mice (S<sub>CGA</sub>) significantly decreased oxLDL-induced neutral lipid accumulation (A) and total cholesterol (B), and stimulates cholesterol efflux (C) in RAW264.7 cells as compared with that from distilled water-treated animals (S<sub>NC</sub>). …”
  18. 558
  19. 559
  20. 560